Fox Run Management L.L.C. Buys Shares of 5,509 Globe Life Inc. $GL

Fox Run Management L.L.C. acquired a new stake in shares of Globe Life Inc. (NYSE:GL) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,509 shares of the company’s stock, valued at approximately $788,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. MAI Capital Management lifted its position in shares of Globe Life by 7,213.4% during the third quarter. MAI Capital Management now owns 5,997 shares of the company’s stock valued at $857,000 after buying an additional 5,915 shares during the last quarter. Waddell & Associates LLC purchased a new stake in Globe Life during the third quarter valued at approximately $246,000. Mufg Securities Americas Inc. boosted its stake in Globe Life by 19.5% in the third quarter. Mufg Securities Americas Inc. now owns 2,185 shares of the company’s stock valued at $312,000 after acquiring an additional 356 shares in the last quarter. Compound Planning Inc. grew its holdings in Globe Life by 8.4% in the third quarter. Compound Planning Inc. now owns 1,886 shares of the company’s stock worth $270,000 after purchasing an additional 146 shares during the last quarter. Finally, Clearstead Advisors LLC grew its holdings in Globe Life by 1.9% in the third quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock worth $754,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling

In related news, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total value of $1,431,400.00. Following the transaction, the chief marketing officer owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. This represents a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 63,629 shares of company stock worth $9,223,785 over the last ninety days. 1.51% of the stock is owned by corporate insiders.

Globe Life Stock Performance

Shares of NYSE GL opened at $146.06 on Friday. The company has a 50 day simple moving average of $141.76 and a two-hundred day simple moving average of $138.69. The stock has a market cap of $11.63 billion, a price-to-earnings ratio of 10.37 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 12 month low of $109.38 and a 12 month high of $152.71.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a boost from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. Globe Life’s payout ratio is presently 7.67%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on GL shares. Morgan Stanley reissued an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research report on Monday, December 15th. Truist Financial increased their price target on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Wells Fargo & Company boosted their price target on Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research note on Wednesday. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, TD Cowen reiterated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $171.33.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.